# Denis Franchimont

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/denis-franchimont/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,922 |
| Field | Inflammatory Bowel Disease |
| h-index | 58 |
| i10-index | 114 |
| Last Known Institution | Université Libre de Bruxelles |
| OpenAlex ID | https://openalex.org/A5029097636 |
| ORCID iD | https://orcid.org/0000-0001-8856-3462 |
| Works | 261 |

## Researcher papers

- [Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease](https://scholariq.org/papers/host-microbe-interactions-have-shaped-the-genetic-architecture-of-inflammatory/)
- [Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease](https://scholariq.org/papers/genome-wide-association-defines-more-than-30-distinct-susceptibility-loci-for/)
- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47](https://scholariq.org/papers/meta-analysis-identifies-29-additional-ulcerative-colitis-risk-loci-increasing/)
- [Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial](https://scholariq.org/papers/ciclosporin-versus-infliximab-in-patients-with-severe-ulcerative-colitis/)
- [Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features](https://scholariq.org/papers/stratification-of-pancreatic-ductal-adenocarcinomas-based-on-tumor-and/)
- [A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis](https://scholariq.org/papers/a-genome-wide-association-study-confirms-pnpla3-and-identifies-tm6sf2-and-mboat7/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [Université Libre de Bruxelles](https://scholariq.org/institutions/universite-libre-de-bruxelles/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.